Rap1, a small GTPase, attracted attention because of its involvement in several aspects of cell adhesion, including integrin-and cadherin-mediated adhesion. Yet, the role of Rap1 genes and of Rap1 effectors for angiogenesis has not been investigated so far. HUVEC express Rap1a and Rap1b mRNA. In order to determine the contribution of Rap1 activity for angiogenesis, we overexpressed Rap1GAP1, a GTPase activating protein, which specifically inhibits Rap1 activity. Overexpression of Rap1GAP1 significantly blocked the angiogenic sprouting and the tube forming activity of HUVEC as well as migration and integrin-dependent adhesion.
Introduction
The term angiogenesis refers to the formation of new blood capillaries from preexisting ones 1, 2 .
Angiogenesis is implicated in many physiological and pathological conditions, including embryonic development, wound healing, tumor growth, rheumatoid arthritis and proliferative retinopathy 1, 2 . Vascular endothelial growth factor (VEGF) is an essential cytokine for vasculogenesis and angiogenesis 3 . Through its receptors, which include two distinct tyrosine kinases, VEGF exerts multiple effects on endothelial cells including proliferation, rapid induction of endothelial permeability, promotion of endothelial cell survival, stimulation of migration and induction of gene expression 3 . Besides VEGF, the fibroblast growth factors (FGFs) are also implicated in angiogenesis 4 . However, the downstream signaling pathways mediating the angiogenic effects of angiogenic growth factors such as VEGF and FGFs are poorly understood.
Integrins are heterodimeric transmembrane proteins consisting of non-covalent bound α -and β subunits mediating cell adhesion to extracellular matrix proteins and bidirectional signaling 5 .
Beyond angiogenic growth factors there is evidence that integrins are implicated in angiogenesis 6 . Specifically, β 1-integrins were shown to play an important role in angiogenesis 6 .
Moreover, angiogenic factors such as VEGF affect integrin activity and function in endothelial cells 7 .
Ras-associated protein (Rap) proteins define a family of highly homologous small GTP-binding proteins belonging to the Ras superfamily, which includes five members, Rap1a, Rap1b, Rap2a, Rap2b, and the recently discovered Rap2c, which are grouped into two subfamilies, Rap1 and Rap2, based on their sequence homology [8] [9] [10] [11] [12] . Small GTPases cycle between an inactive GDPbound conformation and an active GTP-bound conformation. In their active conformation, small GTPases interact with effector proteins, which induce downstream signaling. The GDP/GTP cycle is highly regulated by guanine nucleotide exchange factors (GEF) that induce the release For personal use only. on October 28, 2017 . by guest www.bloodjournal.org From of the bound GDP to be replaced by the more abundant GTP and by GTPase activating proteins (GAP) that promotes GTP hydrolysis 13 .
Rap1a and Rap1b were shown to be essential for inside-out integrin activation and for integrindependent cell-matrix and cell-cell adhesion of various cell types such as leukocytes, platelets, ovarial carcinoma cells, fibroblasts and progenitor cells 10, 11, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . In addition, while this study was under preparation for submission, Chrzanowska-Wodnicka et al have demonstrated that Rap1b is involved in angiogenesis 25 . Moreover, inactivation of Rap1 by overexpression of Rap1GAPII inhibited wound healing in endothelial cells 26 . However, the role of Rap1 for integrin activity regulation, integrin-dependent adhesion and angiogenic sprouting of endothelial cells has not been investigated so far. Furthermore i , the role of Rap1a for the ischemia-induced neovascularization is unclear.
Active (GTP-bound) Rap1a was shown to associate with effector proteins such as RAPL and RIAM, thus mediating the activation of integrins and integrin-dependent adhesion in leukocytes 27, 28 . Beyond integrin-dependent adhesion, Rap1 regulates junctional adhesion, thereby, modulating permeability of endothelial cell monolayers [29] [30] [31] [32] [33] .
Although Rap1 was shown to be important for the regulation of several physiological processes, little information is available about the role of Rap1 in integrin signaling in endothelial cells and angiogenesis. In the present study, we demonstrated that both Rap1a and Rap1b play a key role in integrin-dependent angiogenic functions such as sprouting, tube formation, migration and adhesion of endothelial cells in vitro. In line with these results, Rap1a heterozygote and Rap1a -deficient mice displayed a decreased angiogenic response in the matrigel assay and in the hind limb ischemia model in comparison to wild type mice. Moreover, we provide insights into the Rap1 down-stream signaling pathways and demonstrate that RAPL partly mediates the angiogenic effects of Rap1.
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Materials and Methods

Cells
Human umbilical vein endothelial cells (HUVEC) were purchased from Cambrex (Germany) and cultured in endothelial basal medium (EBM) supplemented with 1 µg/mL hydrocortisone, 12 µg/mL bovine brain extract, 50 µg/mL gentamicin, 50 ng/mL amphotericin-B, 10 ng/mL epidermal growth factor and 10% fetal calf serum until the third passage.
Plasmid constructs and transfection
HUVECs (3.5 × 10 5 cells/6-cm well) were grown to 60-70% confluence and then transfected with 3 μ g of plasmids and 20 µL Superfect (Qiagen, Germany), resulting in a transfection efficiency of about 50% as previously described 34, 35 . The Rap1GAP1 (pcDNA-Flag-Rap1GAP1) was kindly provided by Dr. P.J. Stork (Vollum Insitute, Oregon Health and Science University, Portland, Oregon), the plasmids EGFP-Rap1a, the constitutive active mutant EGFP-Rap1aV12 and GFP-RBD RalGDS were kindly provided by Dr. M. R. Philips (New York University, New York) 36 . We subcloned Rap1a and Rap1aV12 from the EGFP-Rap1a-and EGFP-Rap1aV12vectors in the pcDNA3.1-His vector.
RNA interference
To silence Rap1 and RAPL expression, we performed transfection of siRNA duplex using GeneTrans II (MoBiTec, Germany). Rap1a, Rap1b and RAPL siRNAs were synthesized by Eurogentec (Germany). The Rap1a target sequence was 5′-GCAAGACAGTGGTGTAACT-3′ (Rap1a siRNA I), the Rap1b target sequence was 5'-GTCTGCTTTGACTGTACAA-3' (Rap1b siRNA I). The human RAPL siRNA target sequence was 5′-CTGGAAGACTGCTTCTTCA-3′ (RAPL siRNA I). A non-related, scrambled siRNA was used as a control. Additional sequences are available upon request. Densitometry was performed where indicated for the quantification of the Western blots.
Reverse-transcription PCR
Total RNA was isolated using the RNAeasy Mini Kit (Qiagen, Germany). Afterwards, 1 µg of RNA from each sample was reverse transcribed into cDNA and subjected to conventional PCR.
Primer sequences for PCR were: Rap1a 5'-CGATTGCCAACAGTGTATGCTCG-3' and 5'-ACACCACTGTCTTGCTAAATTCTG-3'; Rap1b 5'-TTTATTCCATCACAGCACAGTCC-3' and 5'-TTTCTGTTAATTTGCCGCACTAGG-3' and RAPL 5'-CCTGGACGAGGAACTGGAAGAC-3' and 5'-CAACCATGAACTTCTTGAGCAGCC-3'.
Tube Formation Assay
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From Two hundred microliters of Matrigel Basement Membrane Matrix (BD Biosciences, Germany) were coated for two hours at 37°C within a 12-well plate (Greiner, Germany). Transfected HUVEC were detached by trypsinization, and after neutralization of trypsin, cells were resuspended in EBM containing 10% FCS. Then, HUVECs (1x10 5 ) were seeded in 1 mL of EBM (10% FCS) on the Matrigel Basement Membrane Matrix. Tube length was quantified after 24 h by measuring the cumulative tube length in five random microscopic fields with a computerassisted microscope (Axiovert 100, Carl Zeiss, Jena, Germany) using the software Axiovision 4.5 (Carl Zeiss, Jena, Germany).
Spheroid-based angiogenic assay
Endothelial-cell spheroids of defined cell numbers were generated as described previously 37 . In brief, HUVEC were suspended in culture medium containing 0.2% (wt/vol) carboxymethylcellulose (Sigma, Germany) and seeded in round-bottom 96-well plates which do not support cell adhesion (Greiner, Frickenhausen, Germany). Under these conditions, all suspended cells contribute to the formation of a single spheroid per well of defined size and cell number (400 cells/spheroid). Spheroids were generated overnight and then embedded into rat collagen I (BD Bioscience, Germany). The spheroid-containing collagen was rapidly transferred into prewarmed 24-well plates and allowed to polymerize (for 30 minutes). Then, 100 µL EBM with or without human basic fibroblast growth factor (bFGF, 50 ng/mL, Peprotech, Germany) was added into the wells. In the experiments using siRNA-silencing, HUVEC were transfected 48 h before the formation of the spheroids with the indicated siRNAs. For the experiments with the neutralizing β 1-antibodies, murine IgG1 (30µg/mL, Ancell, Germany) or anti-β1-integrin (clone 6S6, 30µg/mL, Chemicon, Germany) was added to the collagen gel. After 24 hours, pictures were taken using an Axiovert 100 microscope and a Plan-NEOFLUAR 10x objective. In vitro capillary sprouting was quantified by measuring the cumulative length of sprouts per each 
HUVEC migration
Transwell membranes (8 µm; Costar, Germany) were coated on both sides with fibronectin (2.5 µg/mL; Roche, Mannheim, Germany) or human collagen type I (1 µg/mL; Chemicon, Schwalbach, Germany) overnight at 4°C. HUVEC were detached by trypsinization, and after neutralization of trypsin, cells were resuspended in serum-free EBM containing 0.05% BSA.
Then, HUVEC (50,000 cells/well) were incubated in the upper chamber at 37°C in 5% CO 2 and allowed to migrate for 5 hours toward the lower chamber in the presence or absence of VEGF 50 ng/mL (Peprotech, London, UK). Cells remaining on the upper surface of the transwells membranes were mechanically removed and cells that had migrated to the lower surface were For personal use only. on October 28, 2017. by guest www.bloodjournal.org From 9 fixed with 4% formaldehyde. For quantification cell nuclei were stained with DAPI. Cells migrated into the lower chamber were counted in 5 random microscopic fields using a fluorescence microscope (Axiovert 100, Carl Zeiss, Jena, Germany).
Activation of Rap1 in migrating HUVEC
HUVEC were plated on glass slides coated with 2.5µg/mL fibronectin (Roche, Mannheim, Germany). After 36 h, HUVEC were transfected with GFP-RBD RalGDS . 6 hours after transfection, a scratch wound was created with a cell scraper. After 3 hours, cells were fixed in 3% formaldehyde in PBS for 10 min at room temperature, and DAPI nuclear staining was performed. Cells were analyzed with a confocal microscope for localization of the active Rap1 (LSM510, Carl Zeiss, Jena, Germany).
Total and Phospho-Akt1-ELISA
The experiments were performed 48 h after transfection with the respective siRNAs.
Transfected HUVEC were serum-starved for 2 hours in EBM (0% FCS) and then stimulated where indicated with VEGF (50 ng/mL) for 5 min. After lysis with the Akt-ELISA lysis buffer, Akt-ELISA assays were performed (total Akt1-ELISA and phospho-Akt1 (ser473)-ELISA) using a commercial Akt1-ELISA Kit (Cell Signaling Technology, Frankfurt, Germany). Absorbances
were measured with a plate reader (Synergy HT, Biotek, Germany).
Immunofluorescence staining
The method for the immunofluorescence stainging is described in the Online Supplemental material (Supplemental methods and materials Page 1).
Animal experiments
10
All the animal experiments were approved from the Regional Board of Land Hessen, Darmstadt Germany. The animal experiments are described in the Online Supplemental material (Supplemental methods and materials Page 1).
Statistical analysis
Continuous variables are expressed as mean ± SEM. Comparisons between groups were analyzed by t-test (two-sided) or ANOVA (post hoc test: LSD) for experiments with more than two subgroups (SPSS software). P values <0.05 were considered as statistically significant.
Results
Expression of Rap1a and Rap1b in human endothelial cells
In order to characterize the expression of Rap1a and Rap1b in human endothelial cells, we performed RT-PCR. HUVEC expressed both Rap1a and Rap1b mRNA as assessed by RT-PCR (Supplemental Figure S1A ). Moreover, analysis of a mRNA expression microarray revealed that Rap1a and Rap1b are similarly expressed in HUVEC and in human microvascular endothelial cells (HMVEC) (supplemental Figure S1A and Figure S1B ). We confirmed the expression of Rap1 in HUVEC by Western blot (data not shown). Since VEGF and bFGF are relevant angiogenic growth factors, we investigated their effects on Rap1 activation by using Rap1 activity assays. Both, VEGF and bFGF, rapidly increased the active GTP-bound Rap1 reaching a maximum between 2 and 5 min after stimulation (supplemental Figures S1C and S1D). This activation was reversible within 15 min (supplemental figure S1D). All microarray data has been deposited with Gene Expression Omnibus (GEO) under accession number GSE2040.
Role of Rap1 activity for angiogenic sprouting and tube formation
Since angiogenic growth factors rapidly increase Rap1 activity, we next investigated, whether Rap1 activity is required for angiogenic sprouting and tube formation of endothelial cells in vitro.
Rap1GAP1 is a GTPase-activating protein, which specifically inhibits Rap1a and Rap1b activity 38 . To investigate the role of Rap1 activity in angiogenesis, we employed a 3-dimensional spheroidal system of endothelial differentiation and in vitro angiogenic sprouting 37 . Endothelial cell spheroids were embedded in collagen gels, and outgrowth of capillary-like structures was assessed. Overexpression of Rap1GAP1 significantly blocked the basal and bFGF-induced angiogenic sprouting of HUVEC in this spheroidal culture system ( Figure 1A and 1B).
Consistent with these data, overexpression of Rap1GAP1 led to a significant impairment of tube/network-forming activity of HUVEC in another angiogenic assay, the matrigel assay ( Figure   1C ). Overexpression of Rap1a or a constitutively active Rap1aV12 mutant significantly increased the angiogenic sprouting of HUVEC in comparison to mock-transfected cells ( Figure   1D ). Moreover, the Rap1aV12-induced sprouting of HUVEC was inhibited by a neutralizing β 1integrin antibody ( Figure 1E ). In addition, the neutralizing β 1-integrin antibody also inhibited bFGF-induced angiogenic sprouting of HUVEC (Supplemental Figure S4B ). In conclusion, these data demonstrate that Rap1 activity is required and sufficient to promote in vitro angiogenesis in a β 1-integrin-dependent manner.
Role of Rap1a and Rap1b for angiogenic sprouting
Having demonstrated that Rap1 activity is essential for the angiogenic sprouting of endothelial cells in vitro, we next sought to separately study the role of endogenous Rap1a and Rap1b for angiogenesis. For this purpose, we designed small interfering RNA (siRNA) sequences specifically targeting Rap1a and Rap1b. RT-PCR and Western blot confirmed the efficient and specific suppression of Rap1a and Rap1b by the respective siRNA oligonucleotides (Figure 2A and supplemental Figure S2 ). Interestingly, silencing of Rap1a or Rap1b by siRNA transfection significantly blocked the angiogenic sprouting of HUVEC under basal conditions and upon stimulation with bFGF ( Figure 2B ). Simultaneous silencing of Rap1a and Rap1b induced a minor further decrease in sprout formation, which did not achieve statistical significance compared with silencing of the single genes ( Figure 2B ). As a control for the specificity of this approach, a second Rap1a-and Rap1b-specific siRNA was generated and gave identical results in terms of angiogenic sprouting (data not shown). Remarkably, silencing of both, Rap1a and Rap1b, did not significantly influence the proliferation rate of HUVEC (data not shown).
Taken together, Rap1a and Rap1b are essential for in vitro angiogenesis without affecting proliferation.
Role of Rap1a and Rap1b for endothelial cell migration
Endothelial cell migration is an essential step during angiogenesis. Therefore, we investigated the localization of active (GTP-bound) Rap1 in migrating endothelial cells. For this purpose, we overexpressed a construct containing the Ras-Binding-Domain (RBD) of RalGDS fused with GFP as an indicator of Rap1 activity in HUVEC 36, 39 . Interestingly, active (GTP-bound) Rap1 partly accumulated at the plasma membrane preferentially in the leading front of migrating HUVEC in a scratch wound assay in comparison to non-migrating endothelial cells, which displayed a more random localization of active Rap1 on their cell membrane or localization of active Rap1 to cell-cell contacts ( Figure 3A and data not shown). These data suggested that Rap1 activity may be involved in the regulation of endothelial cell migration. To test this hypothesis, we overexpressed Rap1GAP1 in HUVEC and performed migration assays on the matrix proteins collagen and fibronectin. Remarkably, inhibition of Rap1 activity significantly blocked basal and VEGF-stimulated migration of HUVEC on both matrix proteins ( Figure 3B ).
Moreover, silencing of Rap1a and/or Rap1b inhibited the basal and the VEGF-induced migration of HUVEC on fibronectin ( Figure 3C ) and on collagen (supplemental Figure S3A ).
Role of Rap1a and Rap1b for endothelial cell adhesion and for β 1-integrin affinity regulation
The regulation of cell adhesion to matrix proteins is essential for cell migration 40 and angiogenesis. Therefore, we studied the role of Rap1 activity for the integrin-dependent endothelial cell adhesion on fibronectin and collagen. Overexpression of Rap1GAP1 significantly reduced the adhesion of HUVEC on extracellular matrix proteins fibronectin and collagen ( Figure 4A ). In addition, silencing of Rap1a, Rap1b or of Rap1a and Rap1b, significantly blocked the adhesion of HUVEC on the matrix proteins fibronectin ( Figure 4B Figure 5C ). In conclusion, these data demonstrate that Rap1 is required for appropriate angiogenic signaling in endothelial cells.
Role of Rap1a for in vivo angiogenesis
Next, we studied the role of Rap1a for in vivo angiogenesis. Rap1a -/mice (in C57Bl/J background) are born with a substantially reduced mendelian ratio: 32.3% : 59.1% : 8.6% ratio of Rap1a +/+ , Rap1a +/and Rap1a -/mice, respectively (313 mice born from heterozygote mating). We studied the role of the Rap1a in postnatal angiogenesis by using the Rap1a +/heterozygote mice and the Rap1a-deficient mice (Rap1a -/-). Cells isolated from Rap1a +/heterozygote mice displayed about 50 % reduction of Rap1a mRNA (data not shown).
Moreover, we investigated the role of Rap1a for the ischemia-induced neovascularization using the murine hind limb ischemia model. Strikingly, Rap1a -/and Rap1a +/mice displayed a reduced capillary ( Figure 6A ) and arterioles density ( Figure 6B ) 14 days after the induction of hind limb ischemia in comparison to wild type mice. In line with these results, the perfusion of ischemic muscles detected by ultrasound was reduced in Rap1a -/mice in comparison to wild type mice ( Figure 6C ). In an additional angiogenic model, Rap1a +/heterozygote mice displayed a significant reduction in capillary formation in a matrigel assay in comparison to wild-type (Rap1a +/+ ) mice ( Figure 6D ). In conclusion, Rap1a is essential for postnatal angiogenesis in vivo.
RAPL is a downstream effector of Rap1 mediating angiogenesis
Having demonstrated the importance of Rap1a and Rap1b for angiogenesis, we finally aimed to identify components of the downstream signaling pathway mediating these effects. RAPL is an For personal use only. on October 28, 2017. by guest www.bloodjournal.org From effector of Rap1, which associates with activated (GTP-bound) Rap1 and mediates integrin activation in lymphocytes 27, 42 . Therefore, we studied the role of RAPL in angiogenesis. HUVEC expressed mRNA for RAPL ( Figure 7A ). Silencing of RAPL significantly blocked the angiogenic sprouting and migration of HUVEC ( Figures 7B and Figure 7C ). As a control for the specificity of this approach, a second RAPL-specific siRNA was generated and gave identical results in terms of angiogenic sprouting (Supplemental Figure 4) . In order to investigate the role of RAPL as a possible downstream effector of Rap1 in angiogenesis, we overexpressed the constitutively active mutant Rap1aV12 in combination with scrambled or RAPL siRNA. Whereas the Rap1aV12 mutant increased angiogenic sprouting in scrambled siRNA-transfected cells, the silencing of RAPL inhibited the Rap1aV12-induced sprouting ( Figure 7D and 7E ). However, Rap1aV12 still slightly but significantly increased sprouting formation in HUVEC when cotransfected with RAPL siRNA compared to HUVEC transfected with RAPL siRNA and empty vector, indicating the existence of additional downstream effectors beyond RAPL to mediate angiogenesis ( Figure 7E ). Taken together, these data demonstrate that RAPL is a downstream mediator of Rap1-induced angiogenesis, but also suggest that additional downstream angiogenic effectors of Rap1 may exist.
Discussion
The present study underscores the relevance of Rap1a and Rap1b for integrin function in endothelial cells and in vitro and in vivo angiogenesis. Specifically, the data of the present study In this work, we demonstrated that angiogenic growth factors like VEGF and bFGF rapidly increase Rap1 activity. However, the underlying mechanism is unclear. It is conceivable, that a guanine nucleotide exchange factor (GEF), which potentially acts downstream of the VEGFand bFGF-receptors could mediate this effect. A possible candidate GEF is C3G, a GEF of Rap1, which mediates signals from receptor tyrosine kinases 43 . Indeed, it was shown that C3G
can mediate VEGF-and bFGF-induced signaling in endothelial cells 44, 45 . However, the role of C3G for the bFGF-and VEGF-induced Rap1-activation in endothelial cells is not established.
Further studies are required to clarify the mechanism of VEGF-and bFGF-induced Rap1 activation in endothelial cells.
Remarkably, inhibition of Rap1 activity, or knock down of Rap1a or Rap1b blocked the angiogenic sprouting and tube forming activity of endothelial cells. In line with these results, the Rap1a heterozygote mice displayed a reduced angiogenic response in an in vivo matrigel plug assay and in the hind limb ischemia model. Interestingly, a recent study showed that the Rap1b-For personal use only. on October 28, 2017. by guest www.bloodjournal.org From deficient mice also displayed angiogenic defects 46 . In addition, generation of knock-out mice for C3G and PDZ-GEF, two GEFs of Rap1, led to defective vascular morphogenesis 47, 48 . Taken together, our data clearly demonstrate that Rap1a and Rap1b are involved in the sprouting of endothelial cells and in vivo angiogenesis. However, some of the single Rap1a-and Rap1bdeficient mice are born displaying no vascular defects under normal conditions. The modest phenotype might be explained by a redundant function of Rap1a and Rap1b and it is conceivable that mice lacking the endothelial Rap1a and Rap1b may display a more severe vascular phenotype during embryonic vascular development than the single-deficient mice.
Another possibility is that during vascular development additional signaling pathways may compensate for Rap1a and Rap1b. In line with this results, silencing of Rap1a and Rap1b did not completely abolish the angiogenic sprouting, migration and adhesion of endothelial cells suggesting that additional molecular pathways may mediate these angiogenic effects.
Cell migration is an essential angiogenic function of endothelial cells. The role of Rap1 in cell migration is controversially discussed. It was demonstrated that the migration of C3G-deficient fibroblasts was increased in comparison to wild type cells and that expression of active Rap1 blocked this effect 49 . Similarly, overexpression of Rap1V12 blocked cell motility in carcinoma cells 50 . However, in other studies inhibition of Rap1 blocked cell motility and activation of Rap1 correlated with increased migratory capacity 21, 24, 26, 51 . The data of the present study revealed that overexpression of Rap1GAP1 or silencing of Rap1a and/or Rap1b inhibited the integrindependent endothelial cell migration on fibronectin and collagen. Furthermore, active Rap1 was localized at the front of migrating endothelial cells. These data clearly demonstrate that Rap1a and Rap1b are essential for endothelial cell migration.
Rap1 was shown to be an essential activator of adhesion in a variety of cells (e.g. platelets, leukocytes, fibroblasts) 11, 52 . However, the role of Rap1 for the interaction of endothelial integrins to extracellular matrix proteins has not been investigated so far. Since endothelial cell migration on matrix proteins was reduced by inhibition of Rap1, we additionally studied the role of Rap1a and Rap1b on integrin-affinity and integrin-dependent interaction of endothelial cells with extracellular matrix proteins. Strikingly, inhibition of Rap1 activity or knock down of Rap1a and/or Rap1b significantly blocked the and Rap1b affects the adhesion-dependent Akt phosphorylation and activity mediated by outside-in integrin signaling. Indeed, it has been demonstrated that integrin-dependent outsidein signaling acts synergistically to receptor tyrosine kinases affecting their downstream signaling 55, 56 . Another possibility is that Rap1 or a Rap1 effector act downstream of the VEGFR2 as essential cofactor for Akt phosphorylation. Independent on the mechanism by which Rap1 interferes with Akt signaling VEGF-induced Akt phosphorylation regulates eNOS 34 , Girdin 57 as well as ACAP1 phosphorylation 58 , all involved in migration, thereby, contributing to the migratory defect in Rap1a-and Rap1b-silenced endothelial cells. Akt may also affect integrin affinity and adhesion 59 . Besides Akt phosphorylation, silencing of Rap1a and Rap1b impaired phosphorylation of FAK on tyrosine residue 397 in endothelial cells. This effect is also indicative of an impaired integrin-dependent outside-in signaling, which may affect endothelial cell motility 60 . Furthermore, silencing of Rap1 and Rap1b affected basal ERK phosphorylation.
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From However, VEGF-induced phosphorylation of ERK was not significantly affected. In line with these results, silencing of Rap1a and Rap1b did not affect endothelial cell proliferation, which is controlled by the ERK pathway.
Finally, in the present work we provide new evidence that RAPL is an important mediator of Rap1-induced angiogenesis. Silencing of RAPL as well as silencing of Rap1a and/or Rap1b blocked the migration and angiogenic sprouting of endothelial cells. Consistent with the present findings, another group reported that overexpression of a RAPL mutant perturbed wound healing 26 and that RAPL is involved in the lymphocyte migration 61 . Overexpression of constitutive active Rap1aV12 partly rescued the angiogenic sprouting defect induced by silencing of RAPL in endothelial cells, suggesting that other effector proteins may also mediate the Rap1aV12-induced angiogenic sprouting independent on RAPL.
In leukocytes, RAPL associates with the β 2-integrin, LFA-1 62 . However, LFA-1 is not expressed in endothelial cells but only in hematopoietic cells and, therefore, another mechanism accounts for the effects of RAPL in endothelial cells. Moreover, we could not detect any direct association of RAPL with the Rap1 independent of integrins. In this regard, it was shown that Rap1/RAPL may affect microtubule extension in endothelial cells 26 . However, silencing of Rap1a and Rap1b in HUVEC For personal use only. on October 28, 2017. by guest www.bloodjournal.org From did not affect the extension of microtubule during migration in a scratch wound assay (data not shown) suggesting that the Rap1/RAPL axis at least in our experimental setting affects migration and angiogenic sprouting through a mechanism distinct of microtubule regulation.
Another possibility is, that RAPL may affect downstream of Rap1 the migratory capacity and angiogenic sprouting of endothelial cells through an effect on cell polarization or actin polymerization / protrusion, processes necessary for directional cell migration. Indeed, it was shown that RAPL induces downstream of Rap1 the localization of the CXCR4 receptor to the leading front of leukocytes (polarization) 27 raising the possibility that RAPL may also in endothelial cells affect the localization of growth factor receptors during migration and sprouting.
Additional studies are mandatory, in order to elucidate the molecular mechanism by which RAPL affects migration and angiogenic sprouting of endothelial cells downstream of Rap1.
Interestingly, RIAM is another effector of Rap1, which can affect integrin function in leukocytes 28 . However, we could not detect RIAM protein expression in endothelial cells (data not shown). Additional studies are required to identify new Rap1 effectors, which are involved in mediating Rap1-induced angiogenesis.
Beyond the regulation of integrin affinity and integrin-dependent adhesion to extracellular matrix proteins, which affect the migratory capacity of endothelial cells and their sprouting activity, Rap1 was also shown to regulate the assembly of VE-Cadherin and to regulate vascular permeability 29, [31] [32] [33] . This is an additional pathway, which could affect angiogenesis. A, After 48 hours, HUVEC were serum-starved for 3 hours and then left untreated or stimulated with VEGF (50ng/mL) for 5 min. Cell lysates were subjected to phospho-Akt1-Ser473-or total Akt1-ELISA analysis. B, After 48 hours, HUVEC were serum-starved for 3 hours and then left untreated or stimulated with VEGF (50 ng/mL) for 10 min. Cell lysates were subjected to Western blot analysis using phospho Erk1/2 or total Erk1/2. C, Transfected HUVEC were lysed 48 h after transfection. Cell lysates were subjected to Western blot analysis using antibodies against phospho-Y397-FAK, FAK, Rap1 and tubulin. 
